Investment Reports

Get to know the rationale behind great ideas for you to make sound long term investment decisions.

Refine Search


Date

835/835 Reports

  • Company Update:Infosys
    Company Update:Infosys

    18 Feb 2026

    Stocks covered (1)

    We maintain our BUY rating on the stock at a 23x P/E multiple to its Dec’27 earnings to arrive at a TP of Rs 1,820/share, implying an upside of 31% from the CMP.
  • Top Conviction Ideas - “Road Infra and Others”
    Top Conviction Ideas - “Road Infra and Others”

    18 Feb 2026

    Top Conviction Ideas - “Road Infra and Others”
  • Daily Fundamental View:February 18, 2026
    Daily Fundamental View:February 18, 2026

    18 Feb 2026

    Asian markets are mostly trading higher. The Nikkei and Hang Seng are trading up by 0.98% and 0.52%, respectively, while the Shanghai is trading down by 1.26%.
  • Axis Punch:Bank of Baroda
    Axis Punch:Bank of Baroda

    18 Feb 2026

    Stocks covered (1)

    We recommend a BUY on the stock with a target price of Rs 334/share implying an upside of 10 from the CMP
  • Top Conviction Ideas - “Power and Utilities”
    Top Conviction Ideas - “Power and Utilities”

    18 Feb 2026

    Top Conviction Ideas - “Power and Utilities”
  • Top Conviction Ideas - “Chemicals and Midcaps”
    Top Conviction Ideas - “Chemicals and Midcaps”

    18 Feb 2026

    Top Conviction Ideas - “Chemicals and Midcaps”
  • Top Conviction Ideas - “Metals and Mining”
    Top Conviction Ideas - “Metals and Mining”

    18 Feb 2026

    Top Conviction Ideas - “Metals and Mining”
  • Analyst Meet Update:MAS FINANC SER
    Analyst Meet Update:MAS FINANC SER

    17 Feb 2026

    Stocks covered (1)

    We reiterate our BUY recommendation on the stock. The stock currently trades at 1.9x Sep’27E BV, and we value it at 2.2x Sep’27E BV to arrive at a target price of Rs 425/share, implying an upside of 24% from the CMP.
  • Result Update:Fortis Health.
    Result Update:Fortis Health.

    17 Feb 2026

    Stocks covered (1)

    We maintain a BUY rating on Fortis Healthcare with a target price of Rs 1,070/share